A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder - A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder

Soiken Inc.0 sites6 target enrollmentFebruary 17, 2019

Conditionsone

Overview

No summary available.

Registry

who.int

Start Date

February 17, 2019

End Date

February 17, 2018

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\) Subject who has a mental disease such as depression, schizophrenia, epilepsy or bulimia nervosa 2\) Subject who has allergic disease, cardiovascular, respiratory, thyroid gland malfunction, diabetes, heart disease, brain disease, gout or sleep disorder 3\) Subject who takes regularly medicinal drugs or pharmaceuticals having an effect on the weight 4\) Subject who has the possibility of developing allergic symptoms by the test food (noni allergy) 5\) Subject who has a snacking habit 6\) Female subject who is pregnant or may be pregnant 7\) Female subject who is in lactating 8\) Subject who has blood sample of 200 ml or more within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 9\) Subject who participated in other clinical trials within the past 4 months or currently participates in other clinical trials or plans to participate in other clinical trials during the examination period 10\) Subject deemed unsuitable by the investigator